 The drug was developed by the British pharmaceutical giant Astra Zeneca with the original aim of treating certain types of tumour , but was shelved after it proved ineffective .
Scientists at Yale University in Connecticut in the US have revealed how the treatment , called AZDO5030 restored memory in mice given Alzheimer 's disease .
The drug worked by blocking a process that breaks nerve connections in the brain used to store memory .